Drug-coated Balloon Maintains Good Outcomes in 4-Year IN.PACT Global Study Data

Nov 7, 2019 | DAIC Articles

Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long-term, sustained clinical benefit and safety with low amputation and mortality rates in peripheral artery disease (PAD) patients treated with the device.

X